Summit Investment Advisory Services LLC lifted its position in JPMorgan International Research Enhanced Equity ETF (NYSEARCA:JIRE – Free Report) by 4.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 25,967 shares of the company’s stock after acquiring an additional 1,117 shares during the period. JPMorgan International Research Enhanced Equity ETF comprises approximately 0.8% of Summit Investment Advisory Services LLC’s holdings, making the stock its 22nd largest position. Summit Investment Advisory Services LLC’s holdings in JPMorgan International Research Enhanced Equity ETF were worth $1,519,000 at the end of the most recent reporting period.
A number of other large investors have also made changes to their positions in JIRE. MN Wealth Advisors LLC grew its position in JPMorgan International Research Enhanced Equity ETF by 1.3% during the 3rd quarter. MN Wealth Advisors LLC now owns 68,065 shares of the company’s stock worth $4,494,000 after purchasing an additional 873 shares in the last quarter. 3Chopt Investment Partners LLC purchased a new position in shares of JPMorgan International Research Enhanced Equity ETF during the second quarter valued at $459,000. U.S. Capital Wealth Advisors LLC raised its position in JPMorgan International Research Enhanced Equity ETF by 24.5% during the third quarter. U.S. Capital Wealth Advisors LLC now owns 60,928 shares of the company’s stock valued at $4,023,000 after buying an additional 11,978 shares during the period. Kingsview Wealth Management LLC lifted its stake in JPMorgan International Research Enhanced Equity ETF by 17.1% in the 3rd quarter. Kingsview Wealth Management LLC now owns 15,040 shares of the company’s stock worth $993,000 after acquiring an additional 2,193 shares in the last quarter. Finally, Ascent Group LLC boosted its position in JPMorgan International Research Enhanced Equity ETF by 12.4% during the 2nd quarter. Ascent Group LLC now owns 14,638 shares of the company’s stock worth $916,000 after acquiring an additional 1,611 shares during the period.
JPMorgan International Research Enhanced Equity ETF Price Performance
NYSEARCA:JIRE opened at $61.49 on Friday. The stock has a market cap of $6.14 billion, a PE ratio of 16.01 and a beta of 0.84. The stock’s 50-day moving average is $60.47 and its two-hundred day moving average is $62.74. JPMorgan International Research Enhanced Equity ETF has a fifty-two week low of $57.55 and a fifty-two week high of $67.10.
About JPMorgan International Research Enhanced Equity ETF
The JPMorgan International Research Enhanced Equity ETF (JIRE) is an exchange-traded fund that mostly invests in total market equity. The fund is an actively managed ETF that provides exposure to stocks of any market capitalization from developed markets, excluding North America. JIRE was launched on Jun 10, 2022 and is managed by JPMorgan Chase.
Read More
- Five stocks we like better than JPMorgan International Research Enhanced Equity ETF
- Insider Trading – What You Need to Know
- MP Materials: Rare Earth Elements Powering the EV Boom
- The 3 Best Retail Stocks to Shop for in August
- Verizon’s Turnaround Gains Traction: New Highs Are Likely in 2025
- Transportation Stocks Investing
- Bloom Energy: Powering the Future With Decentralized Energy
Want to see what other hedge funds are holding JIRE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for JPMorgan International Research Enhanced Equity ETF (NYSEARCA:JIRE – Free Report).
Receive News & Ratings for JPMorgan International Research Enhanced Equity ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JPMorgan International Research Enhanced Equity ETF and related companies with MarketBeat.com's FREE daily email newsletter.